Cleared Traditional

K190520 - VITROS XT Chemistry Products GLU-Ca Slides

K190520 is the FDA 510(k) clearance for VITROS XT Chemistry Products GLU-Ca Slides by Ortho-Clinical Diagnostics, Inc.. It is a Class 2 Chemistry device (product code CGA) cleared through the Traditional 510(k) pathway after a 30-day FDA review.

K190520 · Ortho-Clinical Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
30d
Days
Class 2
Risk

K190520 is an FDA 510(k) clearance for the VITROS XT Chemistry Products GLU-Ca Slides. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Ortho-Clinical Diagnostics, Inc. (Rochester, US). The FDA issued a Cleared decision on April 3, 2019 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ortho-Clinical Diagnostics, Inc. devices

Submission Details

510(k) Number K190520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2019
Decision Date April 03, 2019
Days to Decision 30 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 190
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K190520.
i-STAT CHEM8+ cartridge with the i-STAT 1 System
K210958 · Abbott Point of Care, Inc. · Aug 2021
Stat Profile Prime Plus Analyzer System
K200349 · Nova Biomedical Corporation · Mar 2020
i-STAT CHEM8+ cartridge with the i-STAT 1 System
K183678 · Abbott Point of Care, Inc. · Feb 2020
GEM Premier ChemSTAT
K183546 · Instrumentation Laboratory CO · Feb 2019
PTS Professional Chemistry Kit
K182781 · Polymer Technology Systems, Inc. D/B/A Pts Diagnostics · Dec 2018
Stat Profile Prime Plus Analyzer System
K180340 · Nova Biomedical Corporation · Sep 2018